LOS ANGELES, CA / ACCESSWIRE / May 25, 2016 / Signal Genetics, Inc. (SGNL) (Signal), a commercial stage, molecular genetics diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer, today announced that it will be presenting at the 6th annual LD Micro Invitational on Wednesday, June 8th, at 1:00pm PST / 4:00pm EST. Samuel D. Riccitelli, President and Chief Executive Officer of Signal, will be giving the presentation and meeting with investors.
There will be a live webcast of the presentation which will be accessible on the investor relations page of the Company's website at www.signalgenetics.com.
The conference will be held at the Luxe Sunset Bel Air Hotel and will feature 195 companies in the small / micro-cap space.
View Signal Genetics' profile here: http://www.ldmicro.com/profile/sgnl.
About Signal Genetics, Inc.
Signal Genetics, Inc., headquartered in Carlsbad, California, is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. Signal's mission is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions. Signal was founded in January 2010 and became the exclusive licensee in its licensed field to the renowned research on multiple myeloma performed at the University of Arkansas for Medical Sciences, in April 2010.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.
The Ruth Group
SOURCE: Signal Genetics, Inc. via LD Micro